Crispr Therapeutics Ag
CRSP
Revenue
892.00k
▲27.00k▲3.12%
3 Months ChangeAssets
2.03B
▼-136.39M▼-6.30%
3 Months ChangeLiabilities
318.59M
▼-18.36M▼-5.45%
3 Months ChangeFree Cash Flow
-54.15M
▼-163.18M▼-149.67%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-05
Form 10-Q
ID: 0000950170-24-090746
2024-08-05
Form 8-K
ID: 0000950170-24-090727
2024-06-03
Form 8-K
ID: 0000950170-24-067660
2024-05-23
Form 8-K
ID: 0000950123-24-005877
2024-05-08
Form 10-Q
ID: 0000950170-24-055719
2024-05-08
Form 8-K
ID: 0000950170-24-055689
2024-02-21
Form 8-K
ID: 0000950170-24-017568
2024-02-13
Form 8-K
ID: 0001193125-24-033973
2024-02-13
Form 8-K
ID: 0001193125-24-032825
2024-01-16
Form 8-K
ID: 0000950170-24-004616